Overview

A Safety and Efficacy Study to Evaluate Wound Healing

Status:
Completed
Trial end date:
2019-12-19
Target enrollment:
Participant gender:
Summary
To evaluate the safety, efficacy and pharmacokinetic profile of ascending concentrations of the study medication compared with vehicle in subjects with incisional wounds
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Aiviva BioPharma Inc.
AiViva BioPharma, Inc.